Liposomal T cell engager and re-director for tumor cell eradication in cancer immunotherapy

• Main Authors: Fang Xie (Author), Luchen Zhang (Author), Sanyuan Shi (Author), Anjie Zheng (Author), Jiaxing Di (Author), Shanshan Jin (Author), Xuguang Miao (Author), Fenglan Wu (Author), Xiaolong Chen (Author), Yanhong Zhang (Author), Xiaohui Wei (Author), Yuhong Xu (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

T cells are one of the most important effector cells in cancer immunotherapy. Various T cell-dependent bispecific antibody (TDB) drugs that engage T cells for targeted cancer cell lysis are being developed. Here, we describe supra-molecular T-cell redirecting antibody fragment-anchored liposomes (TR...